Not an SEC registrant

BioRidge Pharma, LLC

Customers

None disclosed

Suppliers

1 disclosed

Top supplier share

76.3%

of ARDX revenue · 3M to 2026-06-30

Top supplier by $

$92.2M

ARDX · 3M to 2026-06-30

Latest period

Jun 30, 2026

10-Q filed 2026-08-06

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Suppliers 1

Companies that disclose BioRidge Pharma, LLC as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from BioRidge Pharma, LLC	Period	Trend	Status	Source
ARDX ARDELYX, INC.	76.3%	$92.2M	3M 2026-06-30	−9.2pp	Active	10-Q 2026-08-06
BioRidge Pharma, LLC 76.3 % 61.1 % 80.3 % 62.2 % 10-Q filed 2026-08-06 Period 3M 2026-04-01 to 2026-06-30 (76.3%), 3M 2025-04-01 to 2025-06-30 (61.1%)Accession 0001437402-26-000044 BioRidge Pharma, LLC 85.5 % 63.8 % 10-Q filed 2026-04-30 Period 3M 2026-01-01 to 2026-03-31 (85.5%), 3M 2025-01-01 to 2025-03-31 (63.8%)Accession 0001437402-26-000022 BioRidge Pharma, LLC 65.9 % 75.4 % 24.0 % 10-K filed 2026-02-19 Period FY 2025-01-01 to 2025-12-31 (65.9%), FY 2024-01-01 to 2024-12-31 (75.4%), FY 2023-01-01 to 2023-12-31 (24%)Accession 0001437402-26-000013 BioRidge Pharma, LLC 66.3 % 78.1 % 63.8 % 76.0 % 10-Q filed 2025-10-30 Period 3M 2025-07-01 to 2025-09-30 (66.3%), 3M 2024-07-01 to 2024-09-30 (78.1%)Accession 0001437402-25-000018

Alerts are coming

Get an email when BioRidge Pharma, LLC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.